{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T08:01:59Z","timestamp":1697529719382},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Contracept"],"published-print":{"date-parts":[[1995,9]]},"DOI":"10.1007\/bf01978421","type":"journal-article","created":{"date-parts":[[2005,8,2]],"date-time":"2005-08-02T04:27:06Z","timestamp":1122956826000},"page":"207-225","source":"Crossref","is-referenced-by-count":7,"title":["A single-dose and 3-month clinical\u2014pharmacokinetic study with a new combination oral contraceptive"],"prefix":"10.1007","volume":"11","author":[{"given":"A.","family":"Heuner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Kuhnz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Heger-Mahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Richert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"H\u00fcmpel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01978421_CR1","first-page":"182","volume":"2","author":"W Elger","year":"1986","unstructured":"Elger W, Steinbeck H, Schillinger E, Losert W, Beier S. Endocrine-pharmacological profile of gestodene. Adv Control Deliv Syst. 1986;2:182\u201397.","journal-title":"Adv Control Deliv Syst."},{"key":"BF01978421_CR2","first-page":"459","volume":"35","author":"W Losert","year":"1985","unstructured":"Losert W, Casal-Stenzel J, Buse M. Progestogens with antimineralocorticoid activity. Drug Res. 1985;35:459\u201371.","journal-title":"Drug Res"},{"key":"BF01978421_CR3","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/0002-9378(90)91358-J","volume":"163","author":"U T\u00e4uber","year":"1990","unstructured":"T\u00e4uber U, Kuhnz W, H\u00fcmpel M. Pharmacokinetics of gestodene and ethinyl estradiol after oral administration of a monophasic contraceptive. Am J Obstet Gynecol. 1990;163:1414\u201320.","journal-title":"Am J Obstet Gynecol."},{"key":"BF01978421_CR4","first-page":"1146","volume":"42","author":"L Dibbelt","year":"1992","unstructured":"Dibbelt L, Knuppen R, Kuhnz W, J\u00fctting G. Pharmacokinetics and protein binding of gestodene under treatment with a low-dose combination oral contraceptive for three months. Drug Res. 1992;42:1146\u201352.","journal-title":"Drug Res."},{"key":"BF01978421_CR5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0010-7824(93)90077-K","volume":"48","author":"W Kuhnz","year":"1993","unstructured":"Kuhnz W, Baumann A, Staks T, Dibbelt L, Knuppen R, J\u00fctting G.. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: Serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum. Contraception. 1993;48:303\u201322.","journal-title":"Contraception"},{"key":"BF01978421_CR6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0010-7824(92)90129-H","volume":"46","author":"W Kuhnz","year":"1992","unstructured":"Kuhnz W, Gansau C, Fuhrmeister A. Pharmacokinetics of gestodene in 12 women who received a single oral dose of 0.075 mg gestodene and, after a wash-out phase, the same dose during one treatment cycle. Contraception. 1992;46:29\u201340.","journal-title":"Contraception"},{"key":"BF01978421_CR7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0010-7824(91)90069-R","volume":"43","author":"M Orme","year":"1991","unstructured":"Orme M, Back DJ, Ward S, Green S. The pharmacokinetics of ethinylestradiol in the presence and absence of gestodene and desogestrel. Contraception. 1991;43:305\u201323.","journal-title":"Contraception"},{"key":"BF01978421_CR8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0010-7824(94)90014-0","volume":"50","author":"W Kuhnz","year":"1994","unstructured":"Kuhnz W, Staks T, J\u00fctting G. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: Serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum. Contraception. 1994;50:563\u201379.","journal-title":"Contraception"},{"key":"BF01978421_CR9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0010-7824(93)90118-Q","volume":"48","author":"W Kuhnz","year":"1993","unstructured":"Kuhnz W, Staks T, J\u00fctting G. Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles. Contraception. 1993;48:557\u201375.","journal-title":"Contraception"},{"key":"BF01978421_CR10","unstructured":"Kuhnz W, H\u00fcmpel M, Biere H, Gross D. Influence of repeated oral doses of ethinylestradiol on the total serum clearance of13C-ethinylestradiol in young women. [submitted for publication]."},{"key":"BF01978421_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(91)90122-V","volume":"43","author":"L Dibbelt","year":"1990","unstructured":"Dibbelt L, Knuppen R, J\u00fctting G, Heimann S, Klipping CO, Parikka-Olexik H. Group comparison of serum ethinyl estradiol, SHBG and CBG levels in 83 women using two low-dose combination oral contraceptives for three months. Contraception. 1990;43:1\u201321.","journal-title":"Contraception"},{"key":"BF01978421_CR12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0010-7824(92)90149-N","volume":"46","author":"W Kuhnz","year":"1992","unstructured":"Kuhnz W, Al-Yacoub G, Fuhrmeister A. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation. Contraception. 1992;46:455\u201369.","journal-title":"Contraception"},{"key":"BF01978421_CR13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0002-9378(90)90577-T","volume":"163","author":"M H\u00fcmpel","year":"1990","unstructured":"H\u00fcmpel M, T\u00e4uber U, Kuhnz W et al., Protein binding of active ingredients and comparison of serum ethinyl estradiol, sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of gestodene\/ethinyl estradiol (Femovan) or a combination of desogestrel\/ethinyl estradiol (Marvelon) and single dose ethinyl estradiol bioequivalence from both oral contraceptives. Am J Obstet Gynecol. 1990;163:329\u201333.","journal-title":"Am J Obstet Gynecol."},{"key":"BF01978421_CR14","first-page":"16","volume":"43","author":"W Kuhnz","year":"1993","unstructured":"Kuhnz W, Louton T, Back DJ, Michaelis K. Radioimmunological analysis of ethinylestradiol in human serum. Validation of the method and comparison with a gas chromatographic\/mass spectrometric assay. Drug Res. 1993;43:16\u201321.","journal-title":"Drug Res."},{"key":"BF01978421_CR15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0010-7824(89)90095-4","volume":"40","author":"B Nieuweboer","year":"1989","unstructured":"Nieuweboer B, Tack J, H\u00fcmpel M, T\u00e4uber U. Development and application of a radioimmunoassay of the new progestogen gestagene. Contraception. 1989;40:313\u201323.","journal-title":"Contraception"},{"key":"BF01978421_CR16","volume-title":"TOPFIT 2.0 Pharmacokinetic and pharmacodynamic data analysis system for the PC","author":"G Heinzel","year":"1993","unstructured":"Heinzel G, Woloszczak R, Thomann P. TOPFIT 2.0 Pharmacokinetic and pharmacodynamic data analysis system for the PC. Stuttgart, Jena, New York: Gustav Fischer; 1993."},{"key":"BF01978421_CR17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1530\/acta.0.0760159","volume":"76","author":"U Schwartz","year":"1974","unstructured":"Schwartz U, Hammerstein J. The oestrogenic potency of various contraceptive steroids as determined by their effects on transcortin-binding capacity. Acta Endocrinol. 1974;76:156\u201371.","journal-title":"Acta Endocrinol."},{"key":"BF01978421_CR18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0010-7824(93)90043-7","volume":"47","author":"J Hammerstein","year":"1993","unstructured":"Hammerstein J, Daume E, Simon A et al. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6\u03b2-hydroxycortisol. Contraception. 1993;47:263\u201381.","journal-title":"Contraception"},{"key":"BF01978421_CR19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0010-7824(88)90044-3","volume":"38","author":"C Jung-Hoffmann","year":"1988","unstructured":"Jung-Hoffmann C, Heidt F, Kuhl H. Effect of two oral contraceptives containing 30 \u03bcg ethinylestradiol and 75 \u03bcg gestodene or 150 \u03bcg desogestrel upon various hormonal parameters. Contraception. 1988;38:593\u2013603.","journal-title":"Contraception"},{"key":"BF01978421_CR20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0010-7824(93)90083-J","volume":"48","author":"NM Zamah","year":"1993","unstructured":"Zamah NM, H\u00fcmpel M, Kuhnz W, Louton T, Rafferty J, Back DJ. Absence of an effect of high vitamin C dosage on the systemic availablity of ethinyl estradiol in women using a combination oral contraceptive. Contraception. 1993;48:377\u201391.","journal-title":"Contraception"},{"key":"BF01978421_CR21","first-page":"1130","volume":"42","author":"M Zuo","year":"1992","unstructured":"Zuo M, Karras D, H\u00fcmpel M. Influence of protein binding on the metabolic clearance rate of synthetic progestins in the rat liver perfusion model. Drug Res. 1992;42:1130\u20138.","journal-title":"Drug Res."},{"key":"BF01978421_CR22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01986524","volume":"10","author":"C Fitzgerald","year":"1994","unstructured":"Fitzgerald C, Feichtinger W, Spona J et al. A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation. Adv Contracept. 1994;10:5\u201318.","journal-title":"Adv Contracept"}],"container-title":["Advances in Contraception"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01978421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01978421\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01978421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T20:15:21Z","timestamp":1557778521000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01978421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["BF01978421"],"URL":"https:\/\/doi.org\/10.1007\/bf01978421","relation":{},"ISSN":["0267-4874","1573-7195"],"issn-type":[{"value":"0267-4874","type":"print"},{"value":"1573-7195","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,9]]}}}